KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Gains from Sales and Divestitures (2009 - 2011)

West Pharmaceutical Services recorded quarterly Gains from Sales and Divestitures of -$3963.0 in Q4 2011, up 92.13% quarter-over-quarter from -$50337.0 in Q4 2010, and up 92.13% year-over-year from -$2062.7 in Q4 2010.

West Pharmaceutical Services' Gains from Sales and Divestitures history runs 3 years deep, the most recent figure standing at -$3963.0 for Q4 2011.

  • In Q4 2011, Gains from Sales and Divestitures rose 92.13% year-over-year to -$3963.0; the TTM figure through Dec 2011 stood at -$3963.0 (up 92.13% YoY), while the FY2011 annual figure was -$3963.0, up 92.13% from the prior year.
  • Gains from Sales and Divestitures came in at -$3963.0 for Q4 2011 at West Pharmaceutical Services, up from -$50337.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of -$3963.0 in Q4 2011 to a low of -$50337.0 in Q4 2010.
  • A 3-year average of -$19903.0 and a median of -$5409.0 in 2009 frame the typical range for Gains from Sales and Divestitures.
  • Across the five-year window, Gains from Sales and Divestitures slumped 830.62% in 2010 and jumped 92.13% in 2011, its largest moves.
  • West Pharmaceutical Services' Gains from Sales and Divestitures stood at -$5409.0 in 2009, then plunged by 830.62% to -$50337.0 in 2010, then surged by 92.13% to -$3963.0 in 2011.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered -$3963.0, -$50337.0, and -$5409.0 for Q4 2011, Q4 2010, and Q4 2009 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 -3,963.00
Dec 31, 2011 -3,963.00
Dec 31, 2010 -50,337.00
Dec 31, 2010 -50,337.00
Dec 31, 2009 -5,409.00
Dec 31, 2009 -5,409.00